Literature DB >> 7027011

Dye-sensitized photodynamic inactivation of cells.

J P Pooler, D P Valenzeno.   

Abstract

Living cells may be modified in diverse ways by the combined action of visible light and photosensitizing molecules. The effects appear most frequently as disruptions of subcellular structure, changes in surface membrane function or inhibition of mitotic ability. This review concentrates on the four most thoroughly studied cell types--yeast cells, nerve cells, erythrocytes, and cultured tumor cells. Research on these cells indicates that potency of sensitization depends at least as much on the factors affecting an association between sensitizer and cell prior to illumination as on photochemical properties. While sensitizers which permeate may lead to altered DNA, it appears that surface membrane modification occurs simultaneously and may be critical in the inactivation mechanism. There is much circumstantial evidence suggesting that excited singlet molecular oxygen acts as an intermediate between photoexcited sensitizer and target alteration. Proteins, lipids, and nucleic acids are all susceptible to photosensitized attack, but the correlation between cellular and molecular modification remains ill-defined. The use of the photodynamic process as a therapeutic technique, particularly in the treatment of malignant tumors, holds great promise, but awaits further research to develop greater selectivity of action.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7027011     DOI: 10.1118/1.595020

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  13 in total

1.  A new model for photochemically induced thrombosis in the inner ear microcirculation and the use of hearing loss as a measure for microcirculatory disorders.

Authors:  K Umemura; Y Kohno; H Matsuno; T Uematsu; M Nakashima
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

2.  Protective action of hydroxyethyl rutosides on singlet oxygen challenged cardiomyocytes.

Authors:  H G Olbrich; P Grabisch; A Grossmann; T Rinne; H Klepzig; E Mutschler
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  On the synthesis of neurotransmitter receptor agonists with antagonist potential.

Authors:  D S Crumrine; M D Choubal; J R Kanofsky; J J Feigenbaum
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

4.  Mammalian cerebral cortical tissue responds to low-intensity visible light.

Authors:  P D Wade; J Taylor; P Siekevitz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  A new model of equilibrium dysfunction in the rat induced by photochemical damage to the inner ear's microcirculation.

Authors:  Y Kohno; K Umemura; Y Asai; T Uematsu; M Nakashima
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

Review 6.  Spotlight on verteporfin in subfoveal choroidal neovascularisation.

Authors:  Susan J Keam; Lesley J Scott; Monique P Curran
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Evaluation of ultrasound-assisted thrombolysis using custom liposomes in a model of retinal vein occlusion.

Authors:  Walid F Abdallah; Hitenkumar Patel; Edward G Grant; Bruno Diniz; Gerald J Chader; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-05       Impact factor: 4.799

8.  Photochemically induced thrombosis of the rat coronary artery and functional evaluation of thrombus formation by occurrence of ventricular arrhythmias. Effects of acetylsalicylic acid and a thromboxane A2 synthetase inhibitor of thrombus formation.

Authors:  M Fukuchi; T Uematsu; S Araki; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

Review 9.  Iatrogenic retinal traumas in ophthalmic surgery.

Authors:  Daniele Tognetto; Maria Teresa di Lauro; Daniela Fanni; Adelia Zagidullina; Luca Michelone; Giuseppe Ravalico
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-05       Impact factor: 3.117

Review 10.  Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.

Authors:  Susan J Keam; Lesley J Scott; Monique P Curran
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.